Boston, MA, United States of America

Carles Serra-Pages


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Carles Serra-Pages: Innovator in TRIO Protein Research

Introduction

Carles Serra-Pages is a notable inventor based in Boston, MA. He has made significant contributions to the field of molecular biology, particularly in the study of TRIO proteins. His work has implications for understanding various disorders related to these proteins.

Latest Patents

Carles Serra-Pages holds a patent titled "Trio molecules and uses related thereto." This patent encompasses nucleic acids encoding TRIO proteins, the TRIO proteins themselves, and active portions thereof. Additionally, it includes antibodies that are immunoreactive with TRIO proteins, along with preparations of such compositions. The patent also describes diagnostic and therapeutic assays and reagents for detecting and treating disorders involving aberrant expression or loss of TRIO proteins. Furthermore, assays are provided for identifying agents that modulate the biological function of TRIO proteins.

Career Highlights

Carles Serra-Pages is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to advance research in his field. His work is crucial in the development of new diagnostic and therapeutic strategies.

Collaborations

Throughout his career, Carles has collaborated with esteemed colleagues such as Michel Streuli and Anne Debant. These collaborations have further enriched his research and contributed to the scientific community.

Conclusion

Carles Serra-Pages is a prominent figure in the study of TRIO proteins, with a patent that highlights his innovative contributions to molecular biology. His work at the Dana-Farber Cancer Institute Inc. continues to pave the way for advancements in diagnostics and therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…